You are here

Mounjaro

Novo seeks a cardiovascular boost

Novo seeks a cardiovascular boost

EP Vantage

Flag link:

Noom to offer prescriptions for weight-loss drugs

Noom to offer prescriptions for weight-loss drugs

Yahoo Finance

Flag link:

‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs

‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs

Stat

Flag link:

Lilly drug Mounjaro succeeds in second weight loss study

Lilly drug Mounjaro succeeds in second weight loss study

BioPharma Dive

clinical trials

Flag link:

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy

Fierce Pharma

clinical trials

Flag link:

Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes

Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes

Xtalks

Flag link:

Diabesity drugs and their free ‘contract sales force’

Diabesity drugs and their free ‘contract sales force’

Medical Marketing and Media

Flag link:

Will Eli Lilly Be a Trillion-Dollar Stock by 2030?

Will Eli Lilly Be a Trillion-Dollar Stock by 2030?

Motley Fool

Flag link:

Eli Lilly kicks off consumer campaign for diabetes drug Mounjaro

Eli Lilly kicks off consumer campaign for diabetes drug Mounjaro

Medical Marketing and Media

Flag link:

Eli Lilly's diabetes drug Mounjaro back in stock amid heightened obesity interest

Eli Lilly's diabetes drug Mounjaro back in stock amid heightened obesity interest

Fierce Pharma

Flag link:

Lilly reports fast sales for new diabetes drug

Lilly reports fast sales for new diabetes drug

BioPharma Dive

Flag link:

A year of two halves for US approvals

A year of two halves for US approvals

EP Vantage

Bristol Myers Squibb

Flag link:

Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says

Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says

Medical Marketing and Media

Flag link:

Lilly and Pfizer fight for new territory in obesity and diabetes

Lilly and Pfizer fight for new territory in obesity and diabetes

EP Vantage

Flag link:

Eli Lilly tightens access to diabetes drug, frustrating some people with obesity

Eli Lilly tightens access to diabetes drug, frustrating some people with obesity

Stat

type 2 diabetes

Flag link:

Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025

Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025

Fierce Pharma

type 2 diabetes

drug manufacturing

Flag link:

Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report

Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report

Endpoints

type 2 diabetes

drug manufacturing

Flag link:

Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro

Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro

Xtalks

type 2 diabetes

Flag link:

Lilly sales of new diabetes drug accelerate on rising patient demand

Lilly sales of new diabetes drug accelerate on rising patient demand

BioPharma Dive

Flag link:

Just announced: upcoming late-stage clinical trials in weight loss and diabetes

Just announced: upcoming late-stage clinical trials in weight loss and diabetes

Clinical Trials Arena

clinical trials

Flag link:

Pages